“Real-World Experience and Clinical Utility of a Non-Invasive Gene Expression Rule-Out Test for Melanoma and Additional Validation Against High Risk Driver Mutations in BRAF, NRAS and the TERT Promoter”. SKIN The Journal of Cutaneous Medicine 2 (December 17, 2018): S69. Accessed June 8, 2025. https://skin.dermsquared.com/skin/article/view/465.